The contribution of cellular electrophysiology in the development of antiarrhythmic agents.
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000503:physiopathology; D002415:Cats; D004285:Dogs; D004341:Drug Evaluation; D004594:Electrophysiology; D006168:Guinea Pigs; D006329:Heart Conduction System / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D066298:In Vitro Techniques; D008012:Lidocaine / Q000494:pharmacology; D009203:Myocardial Infarction / Q000503:physiopathology; D011433:Propranolol / Q000494:pharmacology; D011690:Purkinje Fibers / Q000187:drug effects* / Q000502:physiology; D011817:Rabbits; D051381:Rats
D000889:Anti-Arrhythmia Agents; D008012:Lidocaine; D011433:Propranolol